Korean J Obstet Gynecol.  2004 Mar;47(3):445-450.

Immunohistochemical Analysis for p53 and TGF-beta Expression Pattern in Ovarian Epithelial Tumors

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Dan-Kook University, Cheonan, Korea.
  • 2Department of Pathology, College of Medicine, Dan-Kook University, Cheonan, Korea.

Abstract


OBJECTIVE
To verify the pattern of p53 and TGF-beta protein expression in benign and malignant epithelial ovarian tumors.
METHODS
An immunohistochemical technique was applied to formalin-fixed paraffin-embedded samples of 22 benign and 9 malignant epithelial ovarian tumors using p53 monoclonal antibody and TGF-beta polyclonal antibody. Expressions of p53 and TGF-beta protein in two histological types were compared, and correlated with clinico-pathologic findings of the respective cases.
RESULTS
p53 immunoreactivity of high or intermediate degree was detected in 2 out of 22 benign (9%) and 5 out of 9 malignant (55%) cases. On the other hand, intermediate to high TGF-beta expression was found in 17 out of 22 benign (77%), and 3 out of 9 malignant (33%) cases. The prevalence differences of p53 and TGF-beta expression between benign and malignant groups were statistically significant (p<0.05). In addition, the prevalence of immunoreactivities of p53 and TGF-beta in malignant tumor didn't show any association with age, tumor size, histologic types and stage.
CONCLUSION
Our results suggest that p53 expression and loss of TGF-beta expression may play an important role in the malignant transformation of ovarian epithelial cells. However further studies seem to be necessary to know the exact relationship between their roles.

Keyword

p53; TGF-beta; Immnunohistochemistry; Ovarian epithelial tumors

MeSH Terms

Epithelial Cells
Hand
Prevalence
Transforming Growth Factor beta*
Transforming Growth Factor beta
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr